Clinical Trial Update: Efficacy of Favipiravir Against Severe Ebola Virus Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating favipiravir for severe Ebola virus disease has completed, with the update focusing on its efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Favipiravir (favipiravir)

Snippet

Sponsor: Beijing Institute of Pharmacology and Toxicology | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED